Gary Noworatzky
Physician Assistant · Arlington, TXNPI 1013908185
Payments from drug & device makers
Across 281 payments — averaging $18.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$630
- Novo Nordisk$577
- Lilly USA, LLC$530
- Amgen$339
- Abbott$297
- Corcept Therapeutics$297
- plus $3K from 36 others
What the payments were for
- Food & beverage$5,256100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$218
How this compares
$5,256 in reported general payments places this provider in the 90th percentile of 8,308 physician assistant providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 80 | $115,169 |
| MounjaroTirzepatide | 57 | $78,788 |
| TrulicityDulaglutide | 47 | $71,113 |
| FarxigaDapagliflozin Propanediol | 47 | $47,800 |
| JardianceEmpagliflozin | 29 | $26,804 |
| Tresiba Flextouch U-200Insulin Degludec | 24 | $16,838 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $16,269 |
| Tresiba Flextouch U-100Insulin Degludec | 21 | $13,730 |
| JanumetSitagliptin Phos/Metformin Hcl | 12 | $9,701 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 13 | $7,525 |
| Novolog FlexpenInsulin Aspart | 17 | $6,921 |
| Humalog Kwikpen U-100Insulin Lispro | 17 | $5,986 |
| Levemir FlexpenInsulin Detemir | 15 | $5,593 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $3,701 |
| Cabergoline | 20 | $3,091 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $530 | $149,901104 claims |
| Novo NordiskOzempic | $577 | $115,16980 claims |
| AstraZenecaFarxiga | $630 | $47,80047 claims |
| Boehringer IngelheimJardiance | $277 | $26,80429 claims |
| MerckJanumet | $100 | $9,70112 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $71 | $62760 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in Arlington
- Holly GloverArlington$418K
- Keith RegetsArlington$119K
- Amanda WhiteArlington$88K
- Lisa OstrowskiArlington$47K
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Anthony DerenciusSan Antonio$507K
- Brooke HodnickSouthlake$479K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.